Shopping Cart
Remove All
Your shopping cart is currently empty
AZD9898 is an inhibitor of leukotriene-C4 synthetase with an IC50 of 0.28 nM. AZD9898 can be used in studies about asthma. AZD9898 mitigates the GABA binding and hepatic toxicity signal.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $215 | - | In Stock | |
| 5 mg | $538 | - | In Stock | |
| 10 mg | $790 | - | In Stock | |
| 25 mg | $1,270 | - | In Stock | |
| 50 mg | $1,690 | - | In Stock |
| Description | AZD9898 is an inhibitor of leukotriene-C4 synthetase with an IC50 of 0.28 nM. AZD9898 can be used in studies about asthma. AZD9898 mitigates the GABA binding and hepatic toxicity signal. |
| Targets&IC50 | LTC4S:0.28 nM |
| In vivo | AZD9898 (10 and 100 mg/kg; oral) is well tolerated and shows no safety concerns[1]. |
| Molecular Weight | 457.83 |
| Formula | C20H19ClF3N3O4 |
| Cas No. | 2042347-69-1 |
| Smiles | COc1nc(cnc1C(=O)[C@H]1C[C@@H]1C(O)=O)N(CC(C)(C)F)c1cc(Cl)c(F)cc1F |
| Relative Density. | 1.463 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225 mg/mL (491.45 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.